Compound class:
Synthetic organic
Comment: Compound 4 is reported as an inhibitor of SARS-CoV-2 papain-like protease (PL-pro) [1]. It has relatively low potency against the enzyme in a cell-free assay, but is one of the most potent inhibitors of in vitro viral replication in the study.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Compound 4 inhibits in vitro SARS-CoV-2 replication with an EC50 of 1.7 μM [1]. In the same assay GRL-0617 had an EC50 of 1.4 μM (IC50 in enzyme assay 2.3 μM). |
Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|